Found: 15
Select item for more details and to access through your institution.
Circulating tumor DNA molecular analyses and real-world evidence outcomes of FGFR2 amplified gastroesophageal cancers.
- Published in:
- Oncologist, 2024, v. 29, n. 8, p. 672, doi. 10.1093/oncolo/oyae061
- By:
- Publication type:
- Article
FGFR2‐Altered Gastroesophageal Adenocarcinomas Are an Uncommon Clinicopathologic Entity with a Distinct Genomic Landscape.
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. 1462, doi. 10.1634/theoncologist.2019-0121
- By:
- Publication type:
- Article
Initial Report of Second‐Line FOLFIRI in Combination with Ramucirumab in Advanced Gastroesophageal Adenocarcinomas: A Multi‐Institutional Retrospective Analysis.
- Published in:
- Oncologist, 2019, v. 24, n. 4, p. 475, doi. 10.1634/theoncologist.2018-0602
- By:
- Publication type:
- Article
Facilities that service economically advantaged neighborhoods perform surgical metastasectomy more often for patients with colorectal liver metastases.
- Published in:
- 2020
- By:
- Publication type:
- journal article
ASO Visual Abstract: Association of Obesity with Worse Operative and Oncologic Outcomes Among Patients Undergoing Gastric Cancer Resection.
- Published in:
- 2021
- By:
- Publication type:
- Abstract
Association of Obesity with Worse Operative and Oncologic Outcomes for Patients Undergoing Gastric Cancer Resection.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2021, v. 28, n. 12, p. 7040, doi. 10.1245/s10434-021-09880-5
- By:
- Publication type:
- Article
Outcomes of Neoadjuvant Chemotherapy for Clinical Stages 2 and 3 Gastric Cancer Patients: Analysis of Timing and Site of Recurrence.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2021, v. 28, n. 9, p. 4829, doi. 10.1245/s10434-021-09624-5
- By:
- Publication type:
- Article
Outcomes and Molecular Features of Brain Metastasis in Gastroesophageal Adenocarcinoma.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 8, p. e2228083, doi. 10.1001/jamanetworkopen.2022.28083
- By:
- Publication type:
- Article
Clinical and molecular characteristics of early-onset vs average-onset esophagogastric cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 2, p. 299, doi. 10.1093/jnci/djad186
- By:
- Publication type:
- Article
Patient metabolic profile defined by liver and muscle <sup>18</sup>F-FDG PET avidity is independently associated with overall survival in gastric cancer.
- Published in:
- Gastric Cancer, 2024, v. 27, n. 3, p. 548, doi. 10.1007/s10120-024-01485-7
- By:
- Publication type:
- Article
Targeting EGFR in Esophagogastric Cancer.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.553876
- By:
- Publication type:
- Article
<sup>18</sup>F-BMS-986229 PET to Assess Programmed-Death Ligand 1 Status in Gastroesophageal Cancer.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 8, p. 1, doi. 10.2967/jnumed.123.267186
- By:
- Publication type:
- Article
<sup>18</sup>F-BMS-986229 PET to Assess Programmed-Death Ligand 1 Status in Gastroesophageal Cancer.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 5, p. 722, doi. 10.2967/jnumed.123.267186
- By:
- Publication type:
- Article
Noninvasive Assessment of Human Epidermal Growth Factor Receptor 2 (HER2) in Esophagogastric Cancer Using <sup>89</sup>Zr-Trastuzumab PET: A Pilot Study.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 5, p. 724, doi. 10.2967/jnumed.122.264470
- By:
- Publication type:
- Article
Evaluation of the Association of Perioperative UGT1A1 Genotype–Dosed gFOLFIRINOX With Margin-Negative Resection Rates and Pathologic Response Grades Among Patients With Locally Advanced Gastroesophageal Adenocarcinoma: A Phase 2 Clinical Trial.
- Published in:
- JAMA Network Open, 2020, v. 3, n. 2, p. e1921290, doi. 10.1001/jamanetworkopen.2019.21290
- By:
- Publication type:
- Article